Case-Based Roundtable Meetings Spotlight
Case-Based Roundtable Meetings Spotlight: December 2, 2021
Case-Based Roundtable Meetings Spotlight December 1, 2021
Case-Based Roundtable Meeting Spotlight November 1 2021
Case-Based Roundtable Meeting Spotlight November 2, 2021
Case-Based Roundtable Meeting Spotlight October 1 2021
Case-Based Roundtable Meeting Spotlight October 2 2021
Case-Based Roundtable Meeting Spotlight September 2021:Hematologic Malignancies
Case-Based Roundtable Meeting Spotlight September 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight August 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight August 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight July 1 2021
Case-Based Roundtable Meetings Spotlight July 2 2021
Case-Based Roundtable Meetings Spotlight June 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight June 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight May 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight May 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight April 2, 2021
Case-Based Roundtable Meetings Spotlight April 1, 2021
Case-Based Roundtable Meetings Spotlight March 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight March 2021: Hematologic Malignancies
Case-Based Roundtable Meeting Spotlight February 2 2021
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
5